Invention Grant
- Patent Title: Synthetic hepatitis C genome and methods of making and use
- Patent Title (中): 合成丙型肝炎基因组及其使用方法
-
Application No.: US14114808Application Date: 2012-05-02
-
Publication No.: US09512183B2Publication Date: 2016-12-06
- Inventor: Stuart Campbell Ray , Supriya Munshaw , Lin Liu
- Applicant: Stuart Campbell Ray , Supriya Munshaw , Lin Liu
- Applicant Address: US MD Baltimore
- Assignee: The Johns Hopkins University
- Current Assignee: The Johns Hopkins University
- Current Assignee Address: US MD Baltimore
- Agency: John Hopkins Technology Transfer
- International Application: PCT/US2012/036098 WO 20120502
- International Announcement: WO2012/151263 WO 20121108
- Main IPC: C07K14/005
- IPC: C07K14/005 ; C12N9/02 ; G01N33/569 ; A61K39/29 ; C12N7/00 ; A61K39/12 ; A61K39/00

Abstract:
Synthetic representative HCV subtypes, including a 1a and 1b genome, dubbed Bole1a and Bole1b, are provided using an inventive method of Bayesian phylogenetic tree analysis, ancestral sequence reconstruction and covariance analysis. Bole1a branches centrally among 390 full-genome sequences used in its design, a carefully curated 143 sequence full-genome dataset, and separate genomic regions including an independent set of 214 E1E2 sequences from a Baltimore cohort. Bole1a is phylogenetically representative of widely circulating strains. Full genome non-synonymous diversity comparison and 9-mer peptide coverage analysis showed that Bole1a is able to provide more coverage (94% and 78% respectively) than any other sequence in the dataset including H77, a traditional reference sequence. Bole1a also provides unsurpassed epitope coverage when compared to all known T cell epitopes.
Public/Granted literature
- US20140162340A1 SYNTHETIC HEPATITIS C GENOME AND METHODS OF MAKING AND USE Public/Granted day:2014-06-12
Information query